Under the Inflation Reduction Act, medications with the same active ingredient will be treated as the same drug for price ...

Strong efficacy and cardiovascular benefits should allow Novo to continue growing sales of GLP-1 therapies in diabetes. Ozempic and Rybelsus helped Novo gain share over Eli Lilly's once-weekly ...

$85 Billion Deal Creates America's First Coast-to-Coast Rail Operator With the Union Pacific-Norfolk Southern deal, a single company would control coast-to-coast rail shipments for first time in U.S.

UnitedHealth shares continue to struggle after the company issued a fresh outlook for 2025, indicating revenue and adjusted ...

UnitedHealth (UNH) warned rising medical costs will weigh on 2025 earnings with a record-high medical loss ratio, driven by Medicare and outpatient care. Yahoo Finance Senior Reporter Anjalee Khemlani ...

With promising new obesity treatments in the pipeline, 24/7 Wall St. projects huge upside for Novo Nordisk stock through 2030 ...

Some health experts view GLP-1s as a promising option for PCOS, which lacks a standard treatment and affects millions of ...

As the Trump administration begins to make its mark on the Medicare drug price negotiation program, litigation over the ...

The sale represents Clever Culture’s fifth engagement with a leading pharma manufacturer, including AstraZeneca, Bristol ...

Taking a page from Eli Lilly and Novo Nordisk, who have launched online programs to sell their diabetes and obesity drugs ...

NVO shares fall 19.9% year to date amid weak CagriSema data, CEO exit and rising pressure from rivals in obesity care.